Tucanat contains Tucatinib, a targeted therapy used to treat HER2-positive breast cancer, often in combination with other medicines. It helps slow cancer growth, prevent spread, and improve survival in advanced or metastatic cases.
| Composition | Tucatinib |
| Manufacturer | Natco |
| Packing | 60 Tablets |
| Prescribed For | HER2-positive metastatic breast cancer |
| Expiry | December 2027 |
Lenalid contains Lenalidomide 25mg, a prescription medicine used to treat certain types of blood cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
| Composition | Lenalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules in 1 Bottle |
| Prescribed For | Multiple myeloma |
| Expiry | December 2027 |
Xapavir contains Dolutegravir 50mg, an antiretroviral medication used in the treatment of HIV-1 infection. It belongs to the class of drugs known as integrase strand transfer inhibitors (INSTIs).
| Composition | Dolutegravir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | HIV-1 Infection |
| Expiry | December 2027 |
Bracanat is an oral anticancer medicine containing Olaparib 150 mg, used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers.
| Composition | Olaparib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | Ovarian and Breast Cancer |
| Expiry | December 2027 |
Ibrunat contains Ibrutinib 140mg, a targeted cancer therapy used to treat certain blood cancers such as Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström’s Macroglobulinemia (WM).
| Composition | Ibrutinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Blood Cancers |
| Expiry | December 2027 |
Lenvat contains Lenvatinib 10mg, a targeted therapy used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Capsules |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Natdac contains Daclatasvir 60mg, a direct-acting antiviral medication used in combination with other drugs for the treatment of chronic Hepatitis C virus (HCV) infection.
| Composition | Daclatasvir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Pomalid contains Pomalidomide 2mg, an immunomodulatory drug used in the treatment of multiple myeloma (a type of blood cancer), especially in patients who have not responded to other therapies such as lenalidomide and bortezomib.
| Composition | Pomalidomide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 21 Capsules in 1 Bottle |
| Prescribed For | Multiple Myeloma |
| Expiry | December 2027 |
Regonat contains Regorafenib 40 mg, a targeted chemotherapy medicine used to treat certain types of cancers, including colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (liver cancer).
| Composition | Regorafenib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Colorectal Cancer, Liver Cancer and GIST |
| Expiry | December 2027 |
Sutinat 50mg Capsule is an oral anti-cancer medication that contains Sunitinib Malate, a targeted therapy used to treat certain advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Tipanat 20 is an oral chemotherapy medication used in the treatment of advanced or metastatic colorectal cancer and gastric (stomach) cancer. It contains a combination of Trifluridine (antineoplastic agent) and Tipiracil (a thymidine phosphorylase inhibitor).
| Composition | Tipiracil (8.19mg) + Trifluridine (20mg) |
| Manufacturer | Natco Pharma Ltd |
| Packing | 20 Tablets in 1 Bottle |
| Prescribed For | Stomach Cancer |
| Expiry | December 2027 |
Zoldonat 4 mg Injection contains zoledronic acid and is used to treat high blood calcium levels caused by cancer, prevent bone complications in cancers like breast or prostate cancer, and manage conditions such as osteoporosis and Paget’s disease.
| Composition | Zoledronic Acid |
| Manufacturer | Natco Pharma Ltd |
| Packing | 1 Injection in 1 vial |
| Prescribed For | Osteoporosis |
| Expiry | December 2027 |
Hepcinat 400 mg contains Sofosbuvir and is used to treat chronic Hepatitis C virus (HCV) infection in adults and children (aged 3 and above).
| Composition | Sofosbuvir |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Hepatitis C Virus |
| Expiry | December 2027 |
Geftinat 250mg Tablet contains Gefitinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC), especially in patients with EGFR gene mutations.
| Composition | Gefitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
Cazanat 60mg contains Cabozantinib, a targeted therapy used in the treatment of certain types of cancers, including advanced kidney cancer (renal cell carcinoma) and liver cancer (hepatocellular carcinoma).
| Composition | Cabozantinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets |
| Prescribed For | Kidney and Liver Cancer |
| Expiry | December 2027 |
Capnat 500mg tablet contains Capecitabine, a chemotherapy medicine used to treat several cancers, including breast cancer, colon cancer, and rectal cancer.
| Composition | Capecitabine |
| Manufacturer | Natco Pharma Ltd |
| Packing | 100 Tablets |
| Prescribed For | Breast, Colon, Rectal Cancer |
| Expiry | December 2027 |
Apnat 60mg Tablet contains Apalutamide, an anti-androgen medication used in the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).
| Composition | Apalutamide |
| Manufacturer | Natco Pharma Ltd |
| Packing | 120 Tablets |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
Afanat 40mg contains Afatinib, a targeted cancer therapy used to treat non-small cell lung cancer (NSCLC) that is EGFR mutation-positive.
| Composition | Afatinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Tablets |
| Prescribed For | Lung Cancer |
| Expiry | December 2027 |
